DePuy Synthes Spine and DePuy Synthes Biomaterials have gained the exclusive worldwide rights to market LifeNet Health's cellular allograft product.
Spinal Tech
Carlsbad, Calif.-based Aurora Spine has received FDA 510(k) clearance for TiNano spinal fusion implant.
Mazor Robotics has sold its second Renaissance system to Westside Surgical Hospital in Houston.
Smith & Nephew has agreed to acquire ArthroCare for $1.7 billion or $48.25 per share in cash.
The global medical device market is expected to reach $434.4 billion by 2017, according to a new report released by ReportsnReports.com.
Zimmer Holdings reported year-end net earnings of $761 million, up 0.8 percent from 2012, boosted in part by strong fourth quarter sales.
The orthopedic device market is expected to grow at an annual rate of 4.9 percent from 2013 to 2019 and reach a value of $41.2 billion, according to a Transparency Market Research report.
Mazor Robotics will report its fourth quarter and year-end financial results before U.S. markets open on Tuesday, Feb. 25.
Isador Lieberman, MD, of the Texas Back Institute in Plano has performed 250 spine surgery cases using technology from Mazor Robotics, including the Renaissance robotic surgical system.
The global bone graft and substitutes market is expected to increase from $2.1 billion to $2.7 billion by 2020, a compound annual growth rate of 3.8 percent.
